Amida Care Applauds U.S. Preventive Services Task Force for Awarding Long-Acting Injectable PrEP an A Grade
Amida Care released a statement from President and CEO Doug Wirth after long-acting injectable Pre-Exposure Prophylaxis (PrEP) received a recommendation for an A grade from the U.S. Preventive Services Task Force (USPSTF). The recommendation means that Affordable Care Act (ACA)-approved health plans will be required to cover PrEP.